4/A: Celcuity Inc. Director Lance G. Laing Granted 100,000 Stock Options

Lance G. Laing, Chief Science Officer and Director at Celcuity Inc., was granted 100,000 stock options on August 20, 2024, according to a Form 4/A filing with the SEC.

Summary

• Lance G. Laing, a Director and Chief Science Officer of Celcuity Inc., filed an amended Form 4 with the SEC.
• The amendment adds a Power of Attorney exhibit.
• On August 20, 2024, Laing was granted 100,000 stock options with an exercise price of $17.04.
• These options vest over time, with 25,000 shares vesting on August 20, 2025, and the remaining 75,000 vesting monthly over the subsequent three years.
• The options expire on August 20, 2034.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The document simply reports a stock option grant, which is a routine corporate event. There are no indications of significant positive or negative implications.

Positives

• The grant of stock options aligns the director's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the director.

Industry Context

Stock option grants are a common practice in the biotechnology industry to incentivize and retain key personnel. The vesting schedule is typical for such grants.

Comparison to Industry Standards

• Stock option grants are a standard component of compensation packages for executives and directors in publicly traded companies, particularly in the biotech sector.
• Companies like Amgen, Gilead Sciences, and Biogen often use stock options as part of their executive compensation plans.
• The vesting schedule of 25% after one year and the remainder over the following three years is a common vesting structure.
• The exercise price being set at the market price on the grant date is also a standard practice.

Stakeholder Impact

• The stock option grant could potentially dilute existing shareholders if the options are exercised.
• The grant incentivizes the director to work towards increasing shareholder value.

Key Dates